• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体病患者黑质中铁蓄积的生物监测

Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients.

作者信息

Fernández Belén, Ferrer Isidro, Gil Fernando, Hilfiker Sabine

机构信息

Institute of Parasitology and Biomedicine "López-Neyra", Consejo Superior de Investigaciones Científicas (CSIC), Avda del Conocimiento s/n, 18016 Granada, Spain.

Institute of Neuropathology, IDIBELL-University Hospital Bellvitge, University of Barcelona, Llobregat, Spain.

出版信息

Toxicol Rep. 2017;4:188-193. doi: 10.1016/j.toxrep.2017.03.005. Epub 2017 Mar 31.

DOI:10.1016/j.toxrep.2017.03.005
PMID:28529891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5436624/
Abstract

Iron levels in the healthy human brain are known to be high in certain areas such as the substantia nigra (SN), and increase further with age. In addition, there is some evidence for a further increase in iron load in the SN of Parkinson's disease (PD) patients as compared to controls, which correlates with motor disability. Here, we have analyzed total iron levels in cells as well as mouse and human brain samples by atomic absorption spectroscopy (AAS). Our data indicate that iron load is more pronounced in cells with dopaminergic features. Moreover, region-specific differences in iron load reflecting those in the human brain were detected in rodent brains as well. Whilst altered iron load was not observed in other regions also affected in PD patients, we report a significant increase in iron load in the SN of Lewy body disease patients as compared to Alzheimer's disease (AD) patients or controls, which correlates with neurodegeneration in this brain area.

摘要

已知健康人脑中某些区域(如黑质)的铁含量较高,并且会随着年龄的增长进一步增加。此外,有证据表明,与对照组相比,帕金森病(PD)患者黑质中的铁负荷进一步增加,这与运动功能障碍相关。在此,我们通过原子吸收光谱法(AAS)分析了细胞以及小鼠和人脑样本中的总铁含量。我们的数据表明,具有多巴胺能特征的细胞中铁负荷更为明显。此外,在啮齿动物脑中也检测到了反映人类大脑中铁负荷的区域特异性差异。虽然在PD患者也受影响的其他区域未观察到铁负荷改变,但我们报告,与阿尔茨海默病(AD)患者或对照组相比,路易体病患者黑质中的铁负荷显著增加,这与该脑区的神经退行性变相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/0cba05d0cf8b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/1211be2bbfe5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/7149b5e82910/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/73e974af54ad/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/0cba05d0cf8b/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/1211be2bbfe5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/7149b5e82910/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/73e974af54ad/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04c5/5615124/0cba05d0cf8b/gr5.jpg

相似文献

1
Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients.路易体病患者黑质中铁蓄积的生物监测
Toxicol Rep. 2017;4:188-193. doi: 10.1016/j.toxrep.2017.03.005. Epub 2017 Mar 31.
2
Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.采用定量磁化率映射技术对帕金森病患者黑质内铁沉积进行定量分析。
J Neurol Sci. 2018 Mar 15;386:46-52. doi: 10.1016/j.jns.2018.01.008. Epub 2018 Jan 12.
3
Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.神经退行性变和路易体病中的线粒体功能、谷胱甘肽与铁
J Neurol Sci. 1998 Jun 11;158(1):24-9. doi: 10.1016/s0022-510x(98)00095-1.
4
Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.铁蛋白积累与铁蛋白转运体丢失在衰老大脑中的相互作用:对唐氏综合征痴呆、阿尔茨海默病和帕金森病中蛋白质聚集的影响。
Int J Mol Sci. 2022 Jan 19;23(3):1060. doi: 10.3390/ijms23031060.
5
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.AAV1/2 诱导的 A53T-α-突触核蛋白在黑质中的过表达导致具有路易小体样病理学和运动障碍的黑质纹状体系统变性:帕金森病的新小鼠模型。
Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x.
6
Genetics of iron regulation and the possible role of iron in Parkinson's disease.铁调节的遗传学以及铁在帕金森病中的可能作用。
Neurobiol Dis. 2008 Nov;32(2):183-95. doi: 10.1016/j.nbd.2008.07.001. Epub 2008 Jul 11.
7
Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.帕金森病患者黑质腹后部铁含量 3 年内逐渐增加。
Mov Disord. 2019 Jul;34(7):1006-1013. doi: 10.1002/mds.27730. Epub 2019 Jun 10.
8
Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.帕金森病中黑质高回声与铁沉积的共定位分析:一项经颅超声与磁共振成像的多模态图谱研究
Neuroimage Clin. 2020;26:102185. doi: 10.1016/j.nicl.2020.102185. Epub 2020 Feb 1.
9
Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases.帕金森病、路易体痴呆和正常对照病例的黑质和纹状体脑样本中炎症相关分子和营养分子的表达模式改变
Front Neurosci. 2016 Jan 14;9:507. doi: 10.3389/fnins.2015.00507. eCollection 2015.
10
Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease.黑质病理学导致帕金森病纹状体和额部束的微观结构完整性受损。
Mov Disord. 2023 Sep;38(9):1655-1667. doi: 10.1002/mds.29510. Epub 2023 Jun 22.

引用本文的文献

1
Iron mishandling in the brain and periphery in Parkinson's disease.帕金森病中大脑和外周铁处理不当
NPJ Parkinsons Dis. 2025 Aug 18;11(1):246. doi: 10.1038/s41531-025-01089-7.
2
Gut Microbiota-Based Interventions for Parkinson's Disease: Neuroprotective Mechanisms and Current Perspective.基于肠道微生物群的帕金森病干预措施:神经保护机制及当前观点
Probiotics Antimicrob Proteins. 2025 Jan 15. doi: 10.1007/s12602-024-10433-x.
3
Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities.神经退行性变中的小胶质细胞衰老:见解、影响及治疗机遇

本文引用的文献

1
Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements.帕金森病患者脑铁水平的荟萃分析,通过死后和 MRI 测量确定。
Sci Rep. 2016 Nov 9;6:36669. doi: 10.1038/srep36669.
2
Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.通过定量磁化率成像测量帕金森病中铁的区域渐进性积累。
NMR Biomed. 2017 Apr;30(4). doi: 10.1002/nbm.3489. Epub 2016 Feb 8.
3
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
Neuroprotection. 2024 Sep;2(3):182-195. doi: 10.1002/nep3.56. Epub 2024 Sep 15.
4
Postmortem Brain Imaging in Alzheimer's Disease and Related Dementias: The South Texas Alzheimer's Disease Research Center Repository.阿尔茨海默病及相关痴呆症的死后大脑成像:南德克萨斯州阿尔茨海默病研究中心数据库。
J Alzheimers Dis. 2023;96(3):1267-1283. doi: 10.3233/JAD-230389.
5
Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity.在多能细胞中的全基因组筛选确定 Mtf1 是突变型亨廷顿毒性的抑制剂。
Nat Commun. 2023 Jul 5;14(1):3962. doi: 10.1038/s41467-023-39552-9.
6
Neuro-Nutraceutical Polyphenols: How Far Are We?神经营养多酚:我们进展如何?
Antioxidants (Basel). 2023 Feb 21;12(3):539. doi: 10.3390/antiox12030539.
7
Quantitative imaging approaches to understanding biological processing of metal ions.定量成像方法在理解金属离子生物处理中的应用。
Curr Opin Chem Biol. 2022 Aug;69:102152. doi: 10.1016/j.cbpa.2022.102152. Epub 2022 May 11.
8
Is Chelation Therapy a Potential Treatment for Parkinson's Disease?螯合疗法是否是帕金森病的一种潜在治疗方法?
Int J Mol Sci. 2021 Mar 24;22(7):3338. doi: 10.3390/ijms22073338.
9
Elemental quantification and analysis of structural abnormalities in neurons from Parkinson's-diseased brains by X-ray fluorescence microscopy and diffraction.通过X射线荧光显微镜和衍射对帕金森病大脑神经元中的元素进行定量分析及结构异常研究。
Biomed Opt Express. 2020 Jun 2;11(7):3423-3443. doi: 10.1364/BOE.389408. eCollection 2020 Jul 1.
10
Parkinson's disease and iron.帕金森病与铁。
J Neural Transm (Vienna). 2020 Feb;127(2):181-187. doi: 10.1007/s00702-020-02149-3. Epub 2020 Feb 5.
阿尔茨海默病和帕金森病中的铁神经化学:治疗靶点
J Neurochem. 2016 Oct;139 Suppl 1:179-197. doi: 10.1111/jnc.13425. Epub 2016 Feb 10.
4
Quantitative susceptibility mapping of the midbrain in Parkinson's disease.帕金森病中脑的定量磁化率成像
Mov Disord. 2016 Mar;31(3):317-24. doi: 10.1002/mds.26417. Epub 2015 Sep 12.
5
The role of iron in brain ageing and neurodegenerative disorders.铁在大脑衰老和神经退行性疾病中的作用。
Lancet Neurol. 2014 Oct;13(10):1045-60. doi: 10.1016/S1474-4422(14)70117-6.
6
Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease.铁蓄积赋予黑质神经元的脆弱群体神经毒性:对帕金森病的影响。
Mol Neurodegener. 2014 Jul 10;9:27. doi: 10.1186/1750-1326-9-27.
7
Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.大脑中与帕金森病相关的激酶;对疾病发病机制的深入了解。
Front Mol Neurosci. 2014 Jun 24;7:57. doi: 10.3389/fnmol.2014.00057. eCollection 2014.
8
Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy.帕金森病中的铁缺乏症:帕金森病和多系统萎缩中的区域特异性铁调节异常。
J Parkinsons Dis. 2013;3(4):523-37. doi: 10.3233/JPD-130197.
9
A delicate balance: Iron metabolism and diseases of the brain.微妙的平衡:铁代谢与脑部疾病。
Front Aging Neurosci. 2013 Jul 18;5:34. doi: 10.3389/fnagi.2013.00034. eCollection 2013.
10
Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease.帕金森病患者死后大脑颞叶皮质铁含量降低。
Neurology. 2013 Jan 29;80(5):492-5. doi: 10.1212/WNL.0b013e31827f0ebb. Epub 2013 Jan 9.